The first available book on Phase I cancer clinical trials.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Elizabeth A. Eisenhauer was appointed to the Board of Directors of the National Cancer Institute of Canada in 2002, and will become President in June 2006. Through her work with the I.N.D. program and N.C.I.C. C.T.G., she has co-ordinated over 170 Phase I, II and III trials carried out across Canada, the U.S. and Europe. Marc Buyse founded the International Drug Development Institute (I.D.D.I.) in 1991. In addition to his current posts, he has previously been President of the International Society for Clinical Biostatistics and a Board Member of the Society for Clinical Trials. He has an editorial role in the following journals: Biometrical Journal, Clinical Trials, Journal of Clinical Oncology, and Statistical Methods in Medical Research.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: Studibuch, Stuttgart, Deutschland
paperback. Zustand: Gut. 360 Seiten; 9780198567196.3 Gewicht in Gramm: 1. Bestandsnummer des Verkäufers 1009318
Anzahl: 1 verfügbar
Anbieter: bookmarathon, Emmendingen, BW, Deutschland
Zustand: Sehr gut. Auflage: New. 360 Seiten Leichte Lagerspuren! Signatur auf dem Innencover, von wem auch immer. Sie erhalten eine Rechnung mit der darin ausgewiesenen MwSt. Sprache: Englisch Gewicht in Gramm: 554 23,1 x 1,5 x 15,5 cm, Taschenbuch. Bestandsnummer des Verkäufers 11696
Anzahl: 1 verfügbar
Anbieter: Brook Bookstore On Demand, Napoli, NA, Italien
Zustand: new. Questo è un articolo print on demand. Bestandsnummer des Verkäufers af3b237878bcb0dac1aec769ce93c186
Anzahl: Mehr als 20 verfügbar
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: New. Bestandsnummer des Verkäufers 4253092-n
Anzahl: Mehr als 20 verfügbar
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: As New. Unread book in perfect condition. Bestandsnummer des Verkäufers 4253092
Anzahl: Mehr als 20 verfügbar
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
Zustand: New. In. Bestandsnummer des Verkäufers ria9780198567196_new
Anzahl: Mehr als 20 verfügbar
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
Zustand: New. Bestandsnummer des Verkäufers 4253092-n
Anzahl: Mehr als 20 verfügbar
Anbieter: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irland
Zustand: New. Phase I trials are the first step in the study of novel therapeutic approaches. They aim to identify the recommended dose, schedule and pharamcologic behaviour of new drugs, and to describe the adverse effects of treatment. This practical guide discusses the design, conduct, analysis and ethical aspects of Phase I cancer trials. Num Pages: 360 pages, 20 black and white line illustrations, numerous tables. BIC Classification: MJCL; MJF; MMG. Category: (P) Professional & Vocational. Dimension: 232 x 158 x 19. Weight in Grams: 506. . 2006. Paperback. . . . . Bestandsnummer des Verkäufers V9780198567196
Anzahl: Mehr als 20 verfügbar
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
Zustand: As New. Unread book in perfect condition. Bestandsnummer des Verkäufers 4253092
Anzahl: Mehr als 20 verfügbar
Anbieter: AussieBookSeller, Truganina, VIC, Australien
Paperback. Zustand: new. Paperback. Phase I trials are a critical first step in the study of novel therapeutic approaches. They follow years of development in the laboratory, and precede Phase II and III trials where testing of the drug becomes more focused yet is conducted on a wider scale.The primary goals of Phase I trials are to identify the recommended dose, schedule and pharmacologic behaviour of new agents or new combinations of agents, and to describe the adverseeffects of treatment. In cancer therapeutics, such studies have particular challenges. In general, because of the nature of the effects of treatment, most studies are conducted in patients with advancedmalignancy, rather than in healthy volunteers. Furthermore, the endpoints of these trials are usually measures of adverse effects, but increasingly investigators are interested in assessment of the effects of new drugs on their molecular target. These factors render the design, conduct, analysis and ethical aspects of Phase I cancer clinical trials unique.This book provides a practical guide to Phase I cancer trials and is appropriate for oncology trainees or specialistsinterested in understanding cancer drug development. Topics covered include preclinical requirements needed for first-in-man investigation of new agents, principles and statistical design, ethicalconsiderations of Phase I studies, pharmacokinetics, pharmacodynamics, and studies in special populations. Practical information on protocol development, study activation and conduct, as well as how to write reports of the results, are incorporated. Numerous appendices offer document templates to use in Phase I study development, and examples from actual Phase I trials are interspersed throughout, making this a true 'hands-on' guide.In an exciting time in cancer research,as the number and type of new potential anti-cancer drugs is increasing dramatically, this book provides much needed information on the first stage in getting a drug approved. Phase I trials are the first step in the study of novel therapeutic approaches. They aim to identify the recommended dose, schedule and pharamcologic behaviour of new drugs, and to describe the adverse effects of treatment. This practical guide discusses the design, conduct, analysis and ethical aspects of Phase I cancer trials. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. Bestandsnummer des Verkäufers 9780198567196
Anzahl: 1 verfügbar